Jakafi represents the first and only FDA-Approved Treatment For Myeleofibrosis, a potentially life-threatening blood cancer. It is great to see pharmaceutical companies think ahead and provide patient assistance programs for uninsured and under-insured patients to receive the help they need to receive expensive treatments.
People with MF have few treatment options, expensive or not. It is a progressive and eventually life-threatening blood cancer. More information on the product and the company can be found here.